• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重度抑郁症患者对安非他酮治疗反应的认知预测因素及安非他酮的认知效应

Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.

作者信息

Herrera-Guzmán Ixchel, Gudayol-Ferré Esteve, Lira-Mandujano Jennifer, Herrera-Abarca Jorge, Herrera-Guzmán Daniel, Montoya-Pérez Karina, Guardia-Olmos Joan

机构信息

Clínica de Enfermedades Crónicas y de Procedimientos Especiales, Morelia, Michoacán, Mexico.

出版信息

Psychiatry Res. 2008 Jul 15;160(1):72-82. doi: 10.1016/j.psychres.2007.04.012. Epub 2008 May 23.

DOI:10.1016/j.psychres.2007.04.012
PMID:18501971
Abstract

Cognitive effects of antidepressants and cognitive predictors of antidepressant treatment response are recent focuses of interest in the neuropsychology of depression. We studied the cognitive predictors of treatment response to bupropion and its neuropsychological effects in patients with major depressive disorder. Twenty subjects meeting the DSM-IV criteria for major depressive disorder were assessed with the Hamilton Depression Rating Scale and a neuropsychological battery. Subjects were medicated with 150 mg/day of bupropion sustained release for 8 weeks. At the end of the trial, 12 subjects were classified as responders to treatment and 8 were non-responders. Our findings suggest that low pretreatment measures of visual memory and low levels of mental processing speed are predictive of good response to bupropion. The cognitive effects of bupropion after the treatment showed that patients improved in visual memory measures and in mental processing speed. Our results suggest that cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder could be closely related. These findings need to be replicated due to the exploratory nature of the present work.

摘要

抗抑郁药的认知效应以及抗抑郁治疗反应的认知预测因素是近期抑郁症神经心理学领域的研究热点。我们研究了安非他酮治疗反应的认知预测因素及其对重度抑郁症患者的神经心理学影响。对20名符合DSM-IV重度抑郁症标准的受试者进行了汉密尔顿抑郁量表和一套神经心理学测试。受试者服用150毫克/天的缓释安非他酮,持续8周。试验结束时,12名受试者被归类为治疗反应者,8名受试者为无反应者。我们的研究结果表明,治疗前视觉记忆测量值较低以及心理加工速度较低预示着对安非他酮治疗反应良好。治疗后安非他酮的认知效应表明,患者在视觉记忆测量和心理加工速度方面有所改善。我们的结果表明,重度抑郁症患者对安非他酮治疗反应的认知预测因素与安非他酮的认知效应可能密切相关。由于本研究具有探索性,这些发现需要重复验证。

相似文献

1
Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.重度抑郁症患者对安非他酮治疗反应的认知预测因素及安非他酮的认知效应
Psychiatry Res. 2008 Jul 15;160(1):72-82. doi: 10.1016/j.psychres.2007.04.012. Epub 2008 May 23.
2
Mood and neuropsychological changes in women with midlife depression treated with escitalopram.艾司西酞普兰治疗中年抑郁症女性的情绪和神经心理变化。
J Clin Psychopharmacol. 2006 Aug;26(4):361-6. doi: 10.1097/01.jcp.0000227699.26375.f8.
3
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.一种定量脑电图生物标志物在预测重度抑郁症患者对艾司西酞普兰和安非他酮的不同反应或缓解情况方面的有效性。
Psychiatry Res. 2009 Sep 30;169(2):132-8. doi: 10.1016/j.psychres.2009.04.004. Epub 2009 Aug 26.
4
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.安非他酮缓释片与文拉法辛缓释片抗抑郁疗效及耐受性的为期八周的安慰剂对照双盲比较
J Psychopharmacol. 2009 Jul;23(5):531-8. doi: 10.1177/0269881108089602. Epub 2008 Jul 17.
5
Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.安非他酮缓释片对抑郁症特定症状群的影响:基于31项汉密尔顿抑郁量表的分析
Psychopharmacol Bull. 2003 Spring;37(2):67-78.
6
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.抗抑郁药引发的早期改善能否预测疗效/缓解情况?对大量重度抑郁症住院患者的自然主义研究数据进行分析。
J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011. Epub 2008 Nov 22.
7
Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.米氮平与帕罗西汀治疗重度抑郁症:从治疗开始时单药治疗与联合治疗的比较
Eur Neuropsychopharmacol. 2009 Jul;19(7):457-65. doi: 10.1016/j.euroneuro.2009.01.015. Epub 2009 Apr 2.
8
Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder.双盲、安慰剂对照评估缓释安非他酮在老年抑郁症患者中的应用。
J Psychopharmacol. 2010 Apr;24(4):521-9. doi: 10.1177/0269881108100254. Epub 2009 Jan 22.
9
Sertraline treatment of elderly patients with depression and cognitive impairment.舍曲林治疗老年抑郁症伴认知障碍患者
Int J Geriatr Psychiatry. 2003 Feb;18(2):123-30. doi: 10.1002/gps.802.
10
Neuro-cognitive functions in patients of major depression.重度抑郁症患者的神经认知功能
Indian J Physiol Pharmacol. 2007 Jan-Mar;51(1):69-75.

引用本文的文献

1
Cognitive Function as a Predictor of Short-Term Pharmacological Treatment Response in Major Depressive Disorder: Mediating Effect of Mentalization.认知功能作为重度抑郁症短期药物治疗反应的预测指标:心理化的中介作用。
Psychiatry Investig. 2025 May;22(5):522-530. doi: 10.30773/pi.2024.0203. Epub 2025 May 15.
2
Long-Term Cognitive Outcomes of Esketamine Nasal Spray in Treatment-Resistant Depression: A Preliminary Report.艾氯胺酮鼻腔喷雾剂治疗难治性抑郁症的长期认知结局:初步报告
Pharmaceuticals (Basel). 2025 Jan 27;18(2):173. doi: 10.3390/ph18020173.
3
Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.
3-甲基甲卡西酮(3-MMC)剂量递增后的安全性和认知药效学:首例人体新型毒品研究
Neuropsychopharmacology. 2025 Jun;50(7):1084-1092. doi: 10.1038/s41386-024-02042-7. Epub 2024 Dec 24.
4
Oral ketamine effects on dynamics of functional network connectivity in patients treated for chronic suicidality.口服氯胺酮对慢性自杀倾向患者功能性网络连接动力学的影响。
Eur Arch Psychiatry Clin Neurosci. 2024 May 21. doi: 10.1007/s00406-024-01831-x.
5
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research.抑郁认知障碍的药理学靶向治疗:人类临床研究的最新进展和挑战。
Transl Psychiatry. 2022 Nov 17;12(1):484. doi: 10.1038/s41398-022-02249-6.
6
Cold Cognition as Predictor of Treatment Response to rTMS; A Retrospective Study on Patients With Unipolar and Bipolar Depression.冷认知作为重复经颅磁刺激治疗反应的预测指标:一项关于单相和双相抑郁症患者的回顾性研究
Front Hum Neurosci. 2022 Jul 25;16:888472. doi: 10.3389/fnhum.2022.888472. eCollection 2022.
7
Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse.治疗前的奖赏敏感性和额-纹状体静息态功能连接与舍曲林治疗无反应后改用安非他酮的反应相关。
Biol Psychiatry. 2020 Oct 15;88(8):657-667. doi: 10.1016/j.biopsych.2020.04.009. Epub 2020 Apr 23.
8
Cognitive Dysfunction in Major Depressive Disorder: Assessment, Impact, and Management.重度抑郁症中的认知功能障碍:评估、影响及管理
Focus (Am Psychiatr Publ). 2016 Apr;14(2):194-206. doi: 10.1176/appi.focus.20150043. Epub 2016 Apr 7.
9
Bupropion increases activation in nucleus accumbens during anticipation of monetary reward.安非他酮增加了伏隔核在预期金钱奖励时的激活。
Psychopharmacology (Berl). 2019 Dec;236(12):3655-3665. doi: 10.1007/s00213-019-05337-6. Epub 2019 Jul 24.
10
Bilateral Transcranial Magnetic Stimulation on DLPFC Changes Resting State Networks and Cognitive Function in Patients With Bipolar Depression.双侧背外侧前额叶皮质重复经颅磁刺激对双相抑郁患者静息态网络及认知功能的影响
Front Hum Neurosci. 2018 Sep 5;12:356. doi: 10.3389/fnhum.2018.00356. eCollection 2018.